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AbsTrACT
Objective Several lower limb tendinopathy treatment 
modalities involve identification of pathological 
paratendinous or intratendinous neovascularisation to 
target proposed co-location of painful neoneuralisation. 
The ability to reliably locate and assess the degree of 
neovascularity is therefore clinically important. The 
Modified Ohberg Score (MOS) is frequently used to 
determine degree of neovascularity, but reliability has yet 
to be established among Sport and Exercise Medicine 
(SEM) consultants. This study aims to determine inter-rater 
and intra-rater reliability of an SEM consultant cohort when 
assessing neovascularity using the 5-point MOS.
Method Eleven participants (7 male and 4 female) 
provided 16 symptomatic Achilles and patella tendons. 
These were sequentially examined using power 
Doppler (PD) enabled ultrasound (US) imaging by 6 SEM 
consultants who rated neovascular changes seen using 
the MOS. Representative digital scan images were saved 
for rescoring 3 weeks later. Inter-rater and intra-rater 
reliability of the MOS was examined using intraclass 
correlation coefficient (ICC) and Kappa Agreement scores.
results Neovascular changes were reported in 65.6% of 
96 scans undertaken. ICC for inter-rater reliability was 0.86 
and Fleiss Kappa 0.52. ICC for intra-rater reliability was 
0.95 and Weighted Kappa 0.91.
Conclusions Neovascular changes were present in two-
thirds of symptomatic tendons. Excellent SEM consultant 
inter-rater and intra-rater reliability was demonstrated. 
These findings support the use of PD-enabled US to 
assess neovascularity by appropriately experienced SEM 
consultants. Furthermore, future interventional research 
using a similarly experienced SEM consultant cohort 
can be undertaken with assurance that assessment of 
neovascularity will be reliable.
InTrOduCTIOn
Incidence and prevalence of Achilles and 
patellar tendinopathies are increased in 
physically active populations.1–3 During the 
progression of tendinopathic disease, the 
formation and ingrowth of neovascular struc-
tures into the tendon is a widely recognised 
pathological hallmark.4–7 The role of neovas-
cularisation within tendinopathy is the source 
of significant interest regarding its contribu-
tion to the pathophysiology of the injured 
and healing tendon.6 8 It may also be associ-
ated with neoneuralisation9 exacerbated by 
nociceptive stimuli such as glutamate10 and 
substance P.11 This provides an explanation 
as to why the point of ingress of vessels into 
the tendon is often associated with the site 
of maximal pain on palpation.12 Neovascu-
larisation is a normal physiological response 
in early repair, and its continued presence 
is likely to be a result of prolonged overload 
that delays the healing timeline.13 Association 
between neovascularity and pain and func-
tion has been shown in small interventional 
case and longitudinal studies14–17 yet refuted 
in Randomised Controlled Trial (RCT)18 and 
only weakly correlated in a larger prospective 
cohort.7 This supports the theory that neovas-
cularity may be more a sign of chronicity 
than severity. Polidocanol14 and high volume 
image-guided injections (HVIGI)19 target the 
presence of vessels in order to address this 
proposed pain stimulus.14 19 To that end, the 
ability to reliably locate and quantify vascu-
larity is clinically relevant.
The hypoechoic areas seen in tendinop-
athy on gray-scale ultrasound (US) offer 
limited information which can be enhanced 
by the use of power Doppler (PD) to iden-
tify hyperaemic neovasculature.7 10 14 20 21 In 
What are the new findings?
 ► Appropriately trained Sport and Exercise Medicine 
consultants have excellent inter-rater and intra-rater 
reliability using power Doppler enabled ultrasound 
to assess neovascularity in chronic Achilles and 
patellar tendinopathy.
 ► Previously, such results have only been demonstrated 
among sonographers and radiologists.
 ► Neovascularity is present in two-thirds of chronic 
Achilles and patellar tendinopathies.
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clinical practice, there have been 3 methods of assessing 
the degree of neovascularisation. The first is a simple 
statement of whether vessels are either absent or present 
in the tendon structure.8 Depending on the significance 
of degree of vascularity as discussed above, the utility of 
such binary grading is likely to be limited. A second 
system involves determining the PD signal surface area 
by pixel count. Although a seemingly robust method 
of capturing a quantifiable measure of neovascularity, 
these authors recognise that interpretation of findings 
in clinical practice will be both machine and operator 
setting dependent.22 23 A third method was pioneered by 
Ohberg and Alfredson14 who undertook PD US exam-
ination of symptomatic Achilles tendons to understand 
the extent of neovascularity and locate target areas 
for sclerosing polidocanol injections. In this study, 
an experienced sonographer assessed neovascularisa-
tion as 0, 1+, 2+, 3+ or 4+. In the absence of vessels, 
the tendon scored a 0. A score of 1+ was ascribed if 
the tendon showed 1–2 small vessels primarily around 
the anterior surface of the tendon. Scores of 2+, 3+ or 
4+ were given if the vessel contained 2, 3 or more than 4 
vessels respectively throughout its structure. They later 
adapted this score for use in patellar tendinopathy with 
the score of 1+ referring to 1–2 vessels mostly in the 
posterior portion of that tendon.16
Sengkerij et al21 undertook an inter-rater reliability 
study in which a cohort of radiologists undertook PD US 
examinations of symptomatic and asymptomatic Achilles 
tendons and rated the neovascularisation referring to the 
system described above as the Modified Ohberg Score 
(MOS). Of the 50 tendons examined in the study, each 
underwent scans by 2 of 8 radiologists. Excellent reliability 
was found with absolute agreement of 62% and an intra-
class correlation coefficient (ICC) of 0.85. Sunding et al24 
used a more qualitative 4-point MOS for neovascularity: 
0, None; 1, Mild; 2, Moderate; 3, Severe. They therefore 
used Kappa in their analysis of 27 Achilles and 26 patella 
tendons finding good inter-rater agreements of 0.63 and 
0.70 respectively using 2 sonographers.
US scanning is a common skill used frequently in clin-
ical practice, yet there are no data to support its reliability 
among Sport and Exercise Medicine (SEM) consultants. 
This study aims to contribute to future research by estab-
lishing reliability among SEM consultants when assessing 
tendon neovascularity using the 5-point MOS.
MeThOd
Using a power of 80% (β-level=0.8) and an α-level of 
0.05 anticipating good to excellent reliability (P
0
>0.7 to 
P
1
=0.9), the calculations of Walter et al25 were used to 
estimate the requirement for at least 5 raters (n) of 10 
participants (k).
PArTICIPAnTs
All participants gave written informed consent. Partic-
ipants self-identified following advertisement for 
volunteers with Achilles or patella tendon pain. A 
subjective and objective assessment from an experienced 
physiotherapist (JW) against inclusion/exclusion criteria 
(table 1) was conducted consecutively. Participants were 
requested to avoid any heavy sporting or loading activity 
24 hours prior to US examination.
Six SEM consultant raters were recruited to the study 
having completed professional training for a mean of 8 
years (range 1–23 years). Four had undergone additional 
postgraduate training in musculoskeletal US, while the 
remainder had attained significant clinical experience in 
scanning both Achilles and patella tendons.
data collection
Prior to testing, the consultant raters received an 
instructional brief on the examination protocol which 
included standardised positioning of participants, 
surface pressure produced through the probe at the 
contact point, labelling of recorded scans and clarity as 
to the descriptions of the MOS (table 2). Participants 
were subjected to repeat PD US examination by all 6 
raters.
Scans were performed using a Logic 9 US Scanner 
(GE Medical Systems, Chalfont St Giles, UK) with a 
high frequency linear ML 6-15 MHz transducer (GE 
Medical Systems). Consultants oriented themselves to 
the tendon using standard gray-scale US to identify 
areas of the tendon to focus subsequent PD scanning. 
Once PD mode was engaged, the first consultant  when 
scanning a participant’s tendon set and standardised 
the PD gain used for the subsequent consultants. The 
first consultant to scan was varied for each patient to 
control any bias in setting of PD gain. Where possible, 
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
18–60 years of age
Clinical findings of Achilles or patellar 
tendinopathy:
 ► Localised pain to tendon
 ► Pain/stiffness on waking
 ► Pain on commencing loaded activity
 ► Pain after activity
 ► Pain on mobilising after rest
Symptoms within last 12 months lasting 
for period in excess of 2 months
Systemic 
condition causing 
inflammatory 
tendinopathy
Table 2 Description of the 5-point Modified Ohberg Score
Modified Ohberg 
Score Description
0 No vessels
1+ One vessel anterior to the Achilles
One vessel posterior to the patella tendon
2+ One to two vessels throughout the tendon
3+ Three vessels throughout the tendon
4+ Four or more vessels throughout the 
tendon
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participants were scanned in series by all 6 consul-
tants within the same session. To control for changes 
in tendon loading that may affect vessel signal, partici-
pants were instructed to avoid heavy sporting or loading 
activity 24 hours prior to repeat examinations.
To prevent vessel compression, positioning of the 
tendon was strictly controlled. Achilles tendons were 
scanned in the prone position with the foot in a relaxed 
non-dorsiflexed position over the end of the treatment 
couch (figure 1). Patella tendons were scanned in a 
standardised position of approximately 30° of knee 
flexion (figure 2A). Consultants were also permitted to 
scan in full knee extension (figure 2B) to remove any 
tension from the tendon.
data storage
Participants were assigned an anonymised unique 
identifier used to save images on the Logic 9 Scanner. 
Scans were saved once each consultant determined the 
MOS. Consultants were requested to save any scans that 
contributed to them formulating an overall MOS for the 
tendon. All MOS scores were recorded on paper retained 
out of sight of other raters. Three weeks after the initial 
examination, raters rescored the saved scans. Clinical 
information including previous MOS ratings was not 
available to consultant raters at any stage.
statistical analysis
Inter-rater and intra-rater reliability across the cohort of 
consultants was calculated using ICC and Kappa in IBM 
SPSS Statistics V.23 (IBM, Amonk, New York, USA) with 
a one-way random, single measures model. Fleiss defines 
an excellent ICC as higher than 0.75,26 a good ICC as 
0.4–0.75 and poor if less than 0.4. For clinical investiga-
tions, an ICC of 0.60 has been described as the minimally 
acceptable level.27 Fleiss Kappa statistic was used to 
measure the level of agreement between raters, while a 
weighted Kappa was used to allow marginal agreement 
between individual raters’ baseline and follow-up scores.28 
These were calculated using SPSS extension bundles. 
Both ICC and Kappa were used to provide comparability 
across the literature.
resulTs
Eleven participants (7 males and 4 females with a mean 
age of 36.2 years (SD 6.25)) were recruited to the study 
and provided 16 symptomatic tendons. The mean dura-
tion of symptoms was 20.1 months (range 6–96 months).
Presence of neovascularisation
Eight symptomatic Achilles and 8 patella tendons (n=16) 
were assessed by 6 consultant raters (K=6) resulting in 96 
examinations. Neovascularisation was reported in 65.6% 
of scans and the MOS distribution is shown in table 3.
Inter-rater reliability
In 6 tendons (37.5%), there was absolute scoring agree-
ment across all raters, and a further 6 tendons had 
agreement from at least 4 of the 6 raters. This represents 
an agreement of 4 or more consultant raters in 75% of 
the participants. The ICC for inter-rater reliability of 
the MOS was 0.86 (95% CI, 0.76 to 0.94), illustrating 
excellent inter-rater reliability. The Fleiss Kappa agree-
ment for inter-rater reliability was 0.52 (95% CI, 0.45 
to 0.59). It should be noted the more modest result 
Figure 1 Standardised position for ultrasound imaging of 
the Achilles tendon.
Figure 2 (A)Standardised position for US imaging of the patella tendon (position 1). (B) Standardised position for US imaging 
of the patella tendon (position 2). US, ultrasound. 
Table 3 Distribution of the Modified Ohberg Scores across 
all 96 examinations
Modified Ohberg 
Score
Number of scores 
recorded
Percentage of 
scores recorded
0 33 34.4
1+ 23 23.9
2+ 16 16.7
3+ 5 5.2
4+ 19 19.8
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of Fleiss Kappa is not weighted and based on absolute 
agreement.
Intra-rater reliability
Comparison of the agreement between baseline and 
follow-up scores can be found in table 4. Across raters 
absolute agreement between initial and follow-up scans 
occurred in 84 of 95 scans (one scan did not save), repre-
senting 88% of scans undertaken.
The ICC for intra-rater reliability within the cohort 
was 0.95 (95% CI, 0.92 to 0.97) illustrating excellent reli-
ability of the MOS when reviewing scans. The weighted 
Kappa agreement score was 0.91 (95% CI 0.85 to 0.97) 
demonstrating excellent reliability.
dIsCussIOn
This study has demonstrated excellent inter-rater reli-
ability (ICC 0.86) of a cohort of SEM consultants when 
using the MOS to rate neovascularisation in Achilles and 
patella tendons. Furthermore, excellent intra-rater reli-
ability (ICC 0.95) was demonstrated via review of saved 
scans. Neovascularisation was reported in 65.6% of the 
original scans in keeping with previous studies of Achilles 
and patellar tendinopathy.21 29–31 These results suggest 
that diagnostic US scoring of tendinopathic neovascu-
larisation can be reliably employed in the SEM setting. 
The most important variable that will allow results to 
be extrapolated to a wider audience is the degree of 
clinical exposure to tendon assessment and ultrasonog-
raphy clinicians have undertaken. All clinicians involved 
in this study described themselves as highly competent 
in the ultrasonography of Achilles and patella tendons, 
although this was not corroborated independently the 
results are comparable with those reported using radiolo-
gist or sonographer raters.21 24
In terms of distribution of MOS, it can be noted 
(table 3) that there was a lower number of Grade 
3+ scores attributed to any of the primary scans under-
taken. This is in keeping with the findings of Sengkerij 
and colleagues21 who found that only 9% of their scans 
received a 3+ score. An explanation for this is possibly 
that the raters find it easy to identify 1–2 vessels within 
the tendon structure, but once vascularity is more prev-
alent, it may be difficult to differentiate the existence of 
additional single vessels, the result being a lean towards 
a higher score of 4+. As the results of this study agree 
with those of Sengkerij et al,21 it may provide evidence 
to suggest that the 5-point scale is reduced to a 4-point 
scale, with the final score (grade 3) representing 3 or 
more vessels.
This study builds on the work of Sengkerij et al21 who 
did not attempt to control any of the operator variables 
once the PD setting was enabled. Of particular impor-
tance in this respect is the gain setting, which regulates 
the sensitivity of the system to flow.32 Essentially, too high 
a gain and the amount of random noise artefact in the 
form of colour foci in the image will increase, potentially 
affecting the clarity of colour that indicates vascular flow. 
In this study, the first consultant to scan a given partici-
pant was asked to select and set what they considered to 
be an appropriate gain, which other consultants would 
then use and this stayed consistent for that participant. As 
a result, the sensitivity of the system was standardised for 
each participant. Sengkerij et al21 used 2 radiologists each 
scanning session of a larger cohort (n=8). In such an 
uncrossed design, ICC does not readily deal with missing 
data. Using default SPSS settings with a one-way random 
ICC model cases that are not scanned by all raters would 
be excluded from the analysis. One solution to this would 
be to arrange data in 2 columns giving the appearance of 
a full data set from 2 raters exclusively. Collapsing data 
across empty columns and unequal proportions of scans 
undertaken by raters could overestimate the inter-rater 
ICC they reported of 0.85, though such limitations can 
only be assumed.
Arguably, the MOS is only a semiquantitative scale; 
therefore, this study has also used Fleiss and weighted 
Kappa. These favourable results compare well with 
Sunding et al who reported Kappas of 0.63 and 0.70 in 
Achilles and patellar tendinopathy, respectively using 2 
independent sonographers.24 Weighted Kappa, which, 
like ICC, recognises marginal agreement and does not 
extend to comparison of more than 2 data sets. This 
presents a problem for Kappa analysis of more than 2 
raters. The commonly used Fleiss Kappa result in this 
study should be interpreted differently from the other 
results because it can only reward absolute agreement. 
Light’s Kappa, which is the mean of all rating pairs,33 is 
a different solution yet not often reported. Therefore, 
the Fleiss Kappa has been presented in this study along-
side an excellent inter-rater ICC, which has been able to 
provide context.
A strength of this study was the ability to recruit an 
appropriately powered number of consultant raters and 
where possible have them available for sequential scanning 
of all participants. Shoukri et al27 noted the difficulty in 
recruiting a number of suitably qualified specialists within 
the Hospital setting. While a large cohort of SEM consul-
tants undertook ratings, short notice changes in availability 
were a limitation. The initial design aim for each partic-
ipant to be scanned by 6 consultants sequentially in one 
session was achieved for 9 of 16 tendons. The remainder 
had to undertake subsequent scanning sessions (within 
a mean of 7.8 days). Boesen et al22 reported an increase 
Table 4 Agreement between baseline and follow-up 
scoring
Follow-up scan
Baseline 
scan
0 1+ 2+ 3+ 4+
0 29 3 0 0 0
1+ 1 19 2 0 1
2+ 0 2 14 0 1
3+ 0 0 0 4 1
4+ 0 0 0 0 18
copyright.
 o
n
 25 April 2019 by guest. Protected by
http://bmjopensem.bmj.com/
BM
J O
pen Sport Exerc M
ed: first published as 10.1136/bmjsem-2017-000298 on 7 February 2018. Downloaded from 
5Watson J, et al. BMJ Open Sport Exerc Med 2018;4:e000298. doi:10.1136/bmjsem-2017-000298
Open Access
in vessel appearance as an acute response to exercise, 
although postulate that this may be short-lived. As a result, 
those participants that were required to return for subse-
quent scans were requested to refrain from any activity that 
would either aggravate their symptoms or potentially make 
an acute change to the vessel appearance. This variable 
would have a potential to reduce consultant agreement on 
their primary scans of each patient, but despite this, excel-
lent reliability was still demonstrated.
FurTher reseArCh
The findings of this study have direct implications for 
future research and clinical practice. Primarily, a subco-
hort of the consultants in this study are also involved in a 
large RCT34 to investigate the effects of HVIGI (with and 
without steroid) on chronic Achilles and patella tendon 
pain. The neovessels found on scanning of the participants 
will be targeted by the injections delivered, and there-
fore this reliability study serves to provide assurance that 
the consultants are reliable when scoring neovasculature 
presence and extent. Furthermore, it can be extrapolated 
that consultants of similar experience to those in this study 
will provide reliable PD US assessments for future studies 
using the MOS, as either an outcome measure or target 
for intervention. In the clinical setting, this study provides 
evidence to support the use of diagnostic US in SEM clin-
ical practice by proving reliability both in initial scanning 
and in the test-retest situation, such as follow-up scanning 
postintervention.
COnClusIOn
This study demonstrated excellent inter-rater and intra-
rater reliability of the scoring of neovasculature within 
tendon structure among SEM consultants. While this 
contributes to the clinical assessment of patients with 
tendon pain, it does not explain the role of neovascu-
lature in the pathological process or as a source of 
pain in chronic tendinopathy. Well-controlled research 
is required to establish whether procedures targeting 
neovascularisation can effect improvements in validated 
pain and functional outcome measures.
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